AstraZeneca-Oxford Coronavirus Vaccine Trials Paused After Unexpected Illness In Volunteer
Daily briefing: 'Serendipity' boosted Oxford–AstraZeneca vaccine's efficacy
AstraZeneca Covid-19 vaccine trial volunteer dies: Brazil
Impact of a five-dimensional framework on R&D productivity at AstraZeneca | Nature Reviews Drug Discovery
EUR068: Enforcement (No. 2006/857/EC, Case COMP/A.37.507/F3 — AstraZeneca), Decision, 2005
AstraZeneca deal to supply EU with 300 million COVID-19 vaccine doses - CGTN
AstraZeneca Covid-19 vaccine study is put on hold
AstraZeneca partners its way to a genomic bounty | Science | AAAS
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
Egypt - AstraZeneca
Investments in health systems
AstraZeneca is still waiting for FDA go-ahead to resume U.S. trial
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
A leading coronavirus vaccine trial is on hold: scientists react
The COVID vaccine challenges that lie ahead
APO Group - Africa Newsroom / Press release | AstraZeneca to partner with UNICEF to help prevent non-communicable diseases among five million young people worldwide
Israel - AstraZeneca
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020
Oxford Covid-19 vaccine trial put on hold after participant falls ill
AstraZeneca aims to go carbon free by 2025—and it'll spend $1B to do it | FiercePharma
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
COVID-19 clinical MDT experience sharing webcast
AstraZeneca's COVID-19 vaccine shows midphase promise in seniors | FierceBiotech
Halting the Oxford vaccine trial doesn't mean it's not safe – it shows they're following the right process
